Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cumberland Pharmaceuticals (CPIX) Finished Goods (2016)

Historic Finished Goods for Cumberland Pharmaceuticals (CPIX) over the last 4 years, with Q4 2016 value amounting to $2.3 million.

  • Cumberland Pharmaceuticals' Finished Goods rose 5664.42% to $2.3 million in Q4 2016 from the same period last year, while for Dec 2016 it was $2.3 million, marking a year-over-year increase of 5664.42%. This contributed to the annual value of $2.3 million for FY2016, which is 5664.42% up from last year.
  • Latest data reveals that Cumberland Pharmaceuticals reported Finished Goods of $2.3 million as of Q4 2016, which was up 5664.42% from $1.5 million recorded in Q4 2015.
  • In the past 5 years, Cumberland Pharmaceuticals' Finished Goods registered a high of $2.3 million during Q4 2016, and its lowest value of $1.5 million during Q4 2015.